The moderating role of walking in the association between HDL cholesterol and cognitive function among Korean older adults: a nationwide population-based cross-sectional study
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1637180 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Kyuyoung Cho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Development and Family Studies, Pusan National University, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Cholesterol, HDL, Cognition, Walking. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
The biopsychosocial model of dementia emphasizes an integrative approach that takes into account the joint effects of biological and behavioral processes relevant to cognitive function. Based on this model, this study examined the interactive effects of biological (i.e., high-density lipoprotein; HDL) and behavioral (i.e., frequency of walking) factors on cognitive function (measured using KDSQ-C) among South Korean (hereafter “Korean”) older adults. We conducted a subgroup analysis to explore whether the interaction of these factors differs depending on older adults’ history of chronic conditions.
Methods
This study used cross-sectional Korean National Health Insurance Service data from 2009 that included a sample of older adults who remained qualified for health insurance and medical aid ( n = 20,162). Linear regression models that tested for the interaction effects between HDL and frequency of walking on cognition were analyzed separately for two groups – no history of hypertension or diabetes and those with a history of hypertension or diabetes.
Results
Results showed significant interaction effects ( β = −0.024, p < 0.05) between HDL cholesterol and walking only among older adults with a history of chronic diseases. Specifically, more frequent engagement in walking buffered the negative effect of low HDL cholesterol on cognitive function for those with a history of hypertension or diabetes.
Conclusion
These findings show that regular walking significantly attenuates the negative impact of low HDL cholesterol on cognitive function among Korean older adults with a chronic disease history. This highlights the importance of developing tailored intervention programs that emphasize the health benefits of walking, particularly for older adults with hypertension and diabetes, to help mitigate cognitive decline and promote overall cognitive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child Development and Family Studies, Pusan National University, Busan, Republic of Korea.
- Research Institute of Human Ecology, Pusan National University, Busan, Republic of Korea.
- Institute for Engaged Aging, Clemson University, Seneca, SC, United States.
- Department of Psychology, Clemson University, Clemson, SC, United States.
- Office of Long Term Services and Supports, Maryland Department of Health, Baltimore, MD, United States.
Zitieren
APA
Cho, K., Chai, H. W., & Park, M. K. (2025). The moderating role of walking in the association between HDL cholesterol and cognitive function among Korean older adults: a nationwide population-based cross-sectional study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1637180
Vancouver
Cho K, Chai HW, Park MK. The moderating role of walking in the association between HDL cholesterol and cognitive function among Korean older adults: a nationwide population-based cross-sectional study. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1637180
BibTeX
@article{Cho2025,
author = {Cho, Kyuyoung and Chai, Hye Won and Park, Min Kyoung},
title = {The moderating role of walking in the association between HDL cholesterol and cognitive function among Korean older adults: a nationwide population-based cross-sectional study},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1637180}
}
EUVIMED